DNA Origami Scaffold-Based Peptide-Major Histocompatibility Complex Multimers for Spatial Imaging of T Cells
Visualizing the spatial distribution of antigen-specific T cells is essential for understanding immune responses and improving therapeutic strategies. However, detecting low-affinity antigen-specific T cells and enhancing signals from low-abundance populations remain challenging due to limitations in sensitivity. Here, we report DNA origami scaffold-based peptide-major histocompatibility complex multimers (DOS-pMHCs) with precise spatial organization of pMHC and signaling molecules on the nanoscale for enhanced in situ visualization of antigen-specific T cells. The two-dimensional triangular DNA origami precisely organizes pMHCs and signaling molecules with high valency, significantly improving binding to antigen-specific T cells and signal amplification. These DOS-pMHCs facilitate enhanced visualization of antigen-specific T cells in lymphoid tissues compared to traditional tetramers. Moreover, we show that DOS-pMHCs enable the in situ detection of autoimmune T cells with lower affinity T cell receptors (TCRs), which are difficult to identify using traditional tetramers. This in situ detection strategy provides a powerful tool for mapping the spatial distribution of antigen-specific T cells, thus holding great potential for advancing our understanding of immune responses and guiding personalized immunotherapy.
Authors
- Yueyang Sun (ORCID: https://orcid.org/0000-0002-3983-4753)
- Hao Pei (ORCID: https://orcid.org/0000-0002-6885-6708)
- Li Li (ORCID: https://orcid.org/0000-0001-8494-4997)
- Jing Chen (ORCID: https://orcid.org/0000-0003-1835-2373)
- Jia‐Ning Wang (ORCID: https://orcid.org/0000-0003-0135-8832)
- Han Yang (ORCID: https://orcid.org/0000-0002-8455-2579)
Institutions
- Green Chemistry (PL)
- East China Normal University (CN)
Publication Details
- Journal
- ACS Applied Materials & Interfaces
- Published
- 2025-03-13
- DOI
- https://doi.org/10.1021/acsami.5c00383
- Citations
- 3
- Primary Topic
- Immunotherapy and Immune Responses
- Type
- article
- Field-Weighted Citation Impact
- 2.39
Funders
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Science and Technology Commission of Shanghai Municipality
- National Key Research and Development Program of China